期刊
CA-A CANCER JOURNAL FOR CLINICIANS
卷 58, 期 2, 页码 97-110出版社
WILEY
DOI: 10.3322/CA.2007.0003
关键词
-
类别
资金
- NCI NIH HHS [U54 CA119338, U54 CA 119338, P50 CA128613, U01 CA 101244, R01 CA 112643] Funding Source: Medline
- NATIONAL CANCER INSTITUTE [U01CA101244, P50CA128613, U54CA119338, R01CA112643] Funding Source: NIH RePORTER
Recent developments in nanotechnology have provided researchers with new tools for cancer imaging and treatment. This technology has enabled the development of nanoscale devices that can be conjugated with several functional molecules simultaneously, including tumor-specific ligands, antibodies, anticancer drugs, and imaging probes. Since these nanodevices are 100 to 1,000-fold smaller than cancer cells, they can be easily transferred through leaky blood vessels and interact with targeted tumor-specific proteins both on the surface of and inside cancer cells. Therefore, their application as cancer cell-specific delivery vehicles will be a significant addition to the currently available armory for cancer therapeutics and imaging.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据